𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis

✍ Scribed by Gui, Ji-Cong; Yan, Wei-Li; Liu, Xing-Dang

Book ID
120215826
Publisher
Springer
Year
2013
Tongue
English
Weight
345 KB
Volume
14
Category
Article
ISSN
0372-8722

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum ca 50 as a tumor marker in pancrea
Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9
✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different

CA 494β€”a new tumor marker for the diagno
CA 494β€”a new tumor marker for the diagnosis of pancreatic cancer
✍ Helmut Friess; Markus BΓΌchler; Bernhard Auerbach; Alexander Weber; Peter Malfert πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 569 KB

## Abstract In 59 patients with ductal pancreatic cancer the monoclonal antibody (MAb) BW 494, which detects the CA 494 glycoprotein antigen, was analyzed in comparison with the reference tumor markers CA 19‐9 and CEA. Eighty‐one patients with non‐pancreatic malignancies of the gastraintestinal (GI